Natalizumab reduced serum levels of neurofilament light chain in secondary progressive multiple sclerosis patients from the phase 3 ASCEND studyR. Kapoor,F. Sellebjerg,H. -P. Hartung,D. L. Arnold,M. S. Freedman,D. Jeffery,A. Miller,K. R. Edwards,C. M. Singh, I. Chang, Z. Ren,D. Sangurdekar, B. Zhu,S. Sheikh, D. Mehta,P. -R. Ho,N. Campbell, M. Edwards,E. Fisher,B. C. Kieseier,R. A. Rudick, T. PlavinaMULTIPLE SCLEROSIS JOURNAL（2018）引用 9|浏览30暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
